SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-152555
Filing Date
2021-05-06
Accepted
2021-05-06 07:46:04
Documents
15
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326710d8k.htm   iXBRL 8-K 30496
2 EX-99.1 d326710dex991.htm EX-99.1 70148
7 GRAPHIC g326710g0505211048937.jpg GRAPHIC 4784
  Complete submission text file 0001193125-21-152555.txt   284155

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xomao-20210506.xsd EX-101.SCH 4154
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xomao-20210506_def.xml EX-101.DEF 14334
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xomao-20210506_lab.xml EX-101.LAB 23676
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xomao-20210506_pre.xml EX-101.PRE 15369
8 EXTRACTED XBRL INSTANCE DOCUMENT d326710d8k_htm.xml XML 6811
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 21895838
SIC: 2834 Pharmaceutical Preparations